| (CHF) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 642.00K | — |
| Operating expense | — | — |
| Net income | -9.91M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Year to date, MMTX.SW has returned -91.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -91.2% |
| All-time high | CHF 1.90 (Dec 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what CHF1,000 in MMTX.SW would be worth today ›No. MindMaze Therapeutics Holding SA has not paid a dividend in the past 12 months.
MindMaze Therapeutics Holding SA is part of the Healthcare sector.
MindMaze Therapeutics Holding SA has a market cap of 26.29M CHF, based on the latest quote.
